By Shania Kennedy
March 13, 2024 – A research team from Washington University School of Medicine in St. Louis has developed a deep learning (DL)-based approach to help predict which patients with non-small cell lung cancer…
Continue Reading
By Shania Kennedy
March 11, 2024 – Researchers from Mount Sinai have been awarded a four-year, $3 million grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health (NIH) to develop…
Continue Reading
Pioneering AIxSCAN, Inc. introduces the ARC60, an AI-driven tomosynthesis X-ray imaging system poised to revolutionize lung disease diagnosis. Clinical trials demonstrate promising results, igniting anticipation for FDA approval in 2024. Supported by cutting-edge technology…
Continue Reading
Experience the forefront of medical imaging with AIxSCAN’s groundbreaking ARC60 technology. Commencing clinical trials in late 2023, AIxSCAN, Inc. has garnered early success in imaging precision and consistency. Backed by additional seed funding and…
Continue Reading
In 2020, lung cancer, the foremost cause of global cancer-related deaths, took 1.7 million lives, surpassing fatalities from the next three deadliest cancers combined. Early detection significantly improves the five-year survival rate, increasing from…
Continue Reading
What You Should Know: InSilico Medicine, a clinical-stage company utilizing generative artificial intelligence (AI) for drug discovery, reveals the development of an orally bioavailable preclinical candidate compound. This compound targets KIF18A and aims to treat…
Continue Reading
University Hospitals of Leicester NHS Trust has gone live with an AI-powered chest x-ray solution, as part of the multi-NHS site LungIMPACT research study.The trust is using Qure.ai’s qXR AI which is integrated into…
Continue Reading
By Shania Kennedy
February 12, 2024 – Researchers from Mount Sinai have been awarded $4.1 million from the National Heart, Lung, and Blood Institute (NHLBI) at the National Institutes of Health (NIH) to develop artificial intelligence…
Continue Reading
Riverrain’s ClearRead CT technology, chosen by the U.S. Department of Veterans Affairs, is transforming lung cancer diagnostics for nearly 8,000 veterans annually. The software’s AI-powered precision measurements promise consistency, alleviating radiology burnout and talent…
Continue Reading
NHS Cheshire and Merseyside’s Radiology Imaging Network (CAMRIN) has secured funding from the NHS Transformation Directorate’s AI Diagnostic Fund to accelerate the deployment of AI to help diagnose lung cancer patients quicker.Up to £1.2…
Continue Reading
